05 | MD Anderson Cancer Center

Shark Cartilage Shows No Benefit as a Therapeutic Agent for Lung Cancer

May 26, 2010

MD Anderson News Release 05/26/10

In the first scientific study of its kind, shark cartilage extract, AE-941 or Neovastat, has shown no benefit as a therapeutic agent when combined with chemotherapy and radiation for patients with advanced non-small cell lung cancer, according to researchers at The University of Texas MD Anderson Cancer Center.

The study was published in the Journal of the National Cancer Institute; the...

CA-125 Change Over Time Shows Promise as Screening Tool for Early Detection of Ovarian Cancer

May 20, 2010

Blood test currently approved to find recurrence full of new possibility; invasive, high-grade disease uncovered at curable stage

MD...

Research Shows Surgical Procedure Offers New Option for Pediatric Patients with Rare Cancer in Abdomen

May 20, 2010

MD Anderson News Release 05/20/10

A study by a pediatric surgical oncologist from The University of Texas MD Anderson Children's...

Cancer Genetics Pioneer Wins Margaret Kripke Legend Award

May 17, 2010

MD Anderson honor recognizes Janet Rowley, M.D., of University of Chicago

MD Anderson News Release 05/17/10

Janet Davison Rowley, M.D., trail-blazing researcher on the role of genetic variation in cancer, mentor of young scientists and role model for the possibilities of work-life balance, is the second winner of the Margaret Kripke Legend Award from The University of Texas MD Anderson Cancer Center.

Rowley, the Blum-Riese...